European Healthcare Investor Association (E.H.I.A.)’s Post

Our benchmarking forum is unique and the insights helps to shape Life Sciences future capital project delivery - If you are interested in becoming a member, reach out and we can have a chat #insights #benchmarking #Linesight

Successful life sciences deal-making requires the ability to navigate the here and now while also trying to see around corners and predict the future. For those at BIO, join me tomorrow (June 5) for a deep dive into the current choppy waters of deal-making in the current markets, where I have the privilege of talking with Barbara Kosacz, Joseph Baroldi and Stacy Feld to share their insights and perspectives from decades of collective experience across various sectors of the life sciences and biotech industry, including roles as C-suite executives, investors, legal counsel, and board members in a range of life sciences companies and investment funds. https://lnkd.in/gz_ZKaBX

Great to host our latest Quarterly Life Sciences event today with Womble Bond Dickinson (UK) LLP Well done to Ben Foster (DipACB) our Sector Lead and Peter Snaith for putting together a great panel to discuss the funding landscape for Life Sciences business in the North East Thank you to Richard Faulkner Chris McCourt Sam Whitehouse Dr Mike Nicholds & @christian fellowes for their insightful presentations Key takeaways ✅In such an attractive sector, it's crucial to stay open to international sources of capital. ✅Funding can be challenging due to long routes to revenue and profitability, so building a strong management team early on, especially with an experienced CFO, is key to success. This ensures good information and data management, crucial for investors. ✅Spread your pitches wide as many funds struggle with deploying capital. ✅There's a growing appetite for services, diagnostics, and device businesses ✅Having clarity on funding stages, regulatory journey, and validation from sector peers is essential. ✅Having an advisor with a broad network can be a game-changer in navigating these challenges and opening up International Capital

Join Andy Crawford's journey into pharmaceutical commercial investments, where strategic conversations with potential investors pave the path to success. Learn from Andy's approach to investor relations and unlock the key to fostering strong relationships in commercial real estate. 𝐓𝐡𝐢𝐧𝐠𝐬 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐟𝐫𝐨𝐦 𝐭𝐡𝐢𝐬 𝐞𝐩𝐢𝐬𝐨𝐝𝐞: • Lessons you can learn from common mistakes in residential RE investing • The next step after buying your first property investment • Why you should attend the Invest Beyond Multifamily conference • Key questions to start conversations with potential pharmacy professional investors • How you can build trust with investors in the healthcare sector Subscribe so you don't miss out on great content, and if you love the show, leave an honest rating and review! Ep105 Cultivating Trust with Medical Professionals in CRE Syndications with Andy Crawford - Part 1 #StrategicInvesting #FinancialSuccess #InvestorNetworking Link in the comments.

🧬 European Life Sciences deals overview for 2023 & 2024 outlook 📈 https://lnkd.in/dsiQ5NpB Excited to share our latest publication. In this report, we delve into the dynamic landscape of life sciences investments across European targets, highlighting key trends across each deal type, notable deals, and emerging opportunities shaping the industry Explore the full report to stay informed and gain strategic perspectives on the future of life sciences investments in Europe #LifeSciences #Biotech #Investments

We see sustained strong appetite for life science regulatory services globally given the significant incremental value and cost savings that life science sponsors can realize through expediting the regulatory approval process. This category of outsourced life science services remains one of the least outsourced areas today, albeit with one of the fastest projected growth rates and with substantial runway to grow. Moreover, this expertise carries highly strategic value for services providers, as it can serve as the tip-of-the-spear offering, driving early, meaningful, and regular engagement with life science clients, as well as high-impact, high-margin, high-predictability, reoccurring, and entrenched relationships with sponsor clients. Read more about our key perspectives on the market dynamics, growth drivers, and valuation considerations, including recent precedent M&A transactions: https://hubs.li/Q02LGrgY0

🚀 Spotlight on Europe's Life Science Achievements! 🚀 We're thrilled to invite nominations for the Post-IPO Equity Raise of the Year award at the European Lifestars Awards! This is your chance to honor a team that has successfully completed a groundbreaking secondary placement or follow-on equity raise (not debt) on any international exchange, setting new benchmarks in the life sciences sector! This prestigious award acknowledges companies that have excelled in: 💰 Amount and type of funds raised 🏃♂️ Process / speed / allocation fulfillment of securing significant new funds 🤝 Level / reputation of new investors attracted 💼 Post-finance allocation / use of proceeds 🌟 Level of value creation / value realization from the raise To qualify you must: - Be a public company - Be a company with European headquarters - Have raised the funds in the period between 1 September 2023 and 1 August 2024 - The raise must be a secondary placement or follow-on, NOT an IPO Nominate a deserving company today and help us celebrate their dedication to innovation and growth in the European life sciences landscape! 👉 Cast your nomination here: https://lnkd.in/ezjTkn6f ✨ Get inspired by last year’s winner: Watch the video of Bicycle Therapeutics' success story, then nominate this year’s standout performer! #LifestarsAwards #LifeSciences #PostIPO

Pharma’s M&A boom. MedTech’s pivotal year. The impact of GLP-1 popularity. Check out Deloitte’s 5 bold #LSHC M&A predictions for 2024.

🌟 Navigating the US life sciences market just got easier! Check out our 48-page guide. From research institutions to market access strategies, this guide has it all. Get your free copy now and stay ahead in the industry. https://lnkd.in/efBEiK7S #LifeSciences #USMarket  #SupplyChain Chris Howie Mindy Daeschner Mark Stimpfig Ian Collins

🚀 Excited to share our latest resource: "The Ultimate Guide to the US Life Sciences Ecosystem & Supply Chain". This comprehensive guide covers key players, market trends, and regulatory insights. Perfect for researchers, investors, and companies in the life sciences sector. Download your free copy today! #LifeSciences #SupplyChain #USMarket https://lnkd.in/egPMjcp9